May 12, 2022 / 08:30PM GMT
Operator
Greetings, and welcome to the Eledon Pharmaceuticals' first-quarter financial results conference call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. As a reminder, this conference is being recorded today, May 12, 2022.
I would now like to turn the conference call over to Paul Little, Chief Financial Officer of Eledon. Please go ahead.
Paul Little - Eledon Pharmaceuticals, Inc. - CFO
Good afternoon everyone, and thank you for joining Eledon's first-quarter 2022 operating and financial results conference call. I am joined on today's call by David-Alexandre Gros, Chief Executive Officer; Steve Perrin, President and Chief Scientific Officer; and Jeff Bornstein, Chief Medical Officer. Earlier today, Eledon issued a press release announcing financial results for the first quarter ended March 31, 2022. You may access the release under the Investors tab on our company's website at eledon.com.
I would like to remind everyone today that statements made during this conference
Q1 2022 Eledon Pharmaceuticals Inc Earnings Call Transcript
May 13, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers